[{"Assets_0_FY_USD":165836000.0,"CommonStockSharesOutstanding_0_FY_shares":34619000.0,"EarningsPerShareBasic_1_FY_USD":0.03,"EarningsPerShareBasic_4_FY_USD":0.0,"EarningsPerShareDiluted_1_FY_USD":0.03,"EarningsPerShareDiluted_4_FY_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":25508000.0,"NetIncomeLoss_1_FY_USD":1006000.0,"NetIncomeLoss_4_FY_USD":-92000.0,"StockholdersEquity_0_FY_USD":138202000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":34381000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":34381000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20180228"}]